Does endometrial αvβ3 vitronectin (β3) expression in endometriosis (ENDO) patients predict enhanced outcomes after prolonged GnRH agonist (GnRHa) therapy prior to in vitro fertilization (IVF)?

Eric S. Surrey, A K Lietz, R.L. Gustofson, D.A. Minjarez, William B. Schoolcraft
In: Fertility and Sterility · 2007 · vol. 88 , pp. S137 · doi:10.1016/j.fertnstert.2007.07.440 · W2055071812
article OA: closed CC0
Limited metadata. Only one source feed has indexed this record so far — no abstract, full text, or open-access copy is available through Endo Lab. The publisher's page (linked below) is the canonical location for the actual content. If you have institutional access, use "Find at my library".
View at publisher → View on OpenAlex
⚙ AI-generated summary by claude@2026-06, 2026-06-08 ⓘ

This study investigated whether endometrial αvβ3 vitronectin expression in endometriosis patients predicts improved outcomes following prolonged GnRH agonist therapy before IVF.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

My notes (saved in your browser only)

Condition tags

endometriosis

Citation neighborhood (no data yet)

We don't have any in-corpus citations linked to this paper yet. The paper's references may be in our DB but unresolved to ``paper_id`` (resolution happens at ingest when the cited DOI matches a row we already have). Run the cross-source citation reconcile pass to retry.

Source provenance

openalex
last seen: 2026-06-10T17:14:06.276822+00:00
unpaywall
last seen: 2026-06-02T02:00:03.124865+00:00
License: CC0 · commercial use OK